Protein Biomarkers of Adverse Clinical Features and Events in Sarcomeric Hypertrophic Cardiomyopathy

Proteomic profiling of sarcomeric HCM identified biomarkers associated with adverse imaging and clinical phenotypes. These circulating proteins are part of both established pathways, including neurohormonal activation and fibrosis, and less familiar pathways, including endothelial function and inflammatory proteins less well characterized in HCM. These findings highlight the value of plasma profiling to identify biomarkers of risk and to gain further insights into the pathophysiology of HCM.

Authors

Institutions

Publication Details

Journal
Circulation Heart Failure
Published
2024-11-05
DOI
https://doi.org/10.1161/circheartfailure.124.011707
Citations
5
Primary Topic
Cardiomyopathy and Myosin Studies
Type
article
Field-Weighted Citation Impact
2.01

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Protein Biomarkers of Adverse Clinical Features and Events in Sarcomeric Hypertrophic Cardiomyopathy

Carolyn Yung Ho, Petr Jarolı́m, Usman A. Tahir, Julissa Zelaya-Portillo et al.
5 citations
Circulation Heart Failure
Cardiomyopathy and Myosin Studies
2.01
article

Protein Biomarkers of Adverse Clinical Features and Events in Sarcomeric Hypertrophic Cardiomyopathy

Carolyn Yung Ho, Petr Jarolı́m, Usman A. Tahir, Julissa Zelaya-Portillo, Paul Kolm, Milind Y. Desai, Hugh Watkins, Christopher M. Kramer, Shuliang Deng, Matthias G. Friedrich, Robert E. Gerszten, William S. Weintraub, Michael Jerosch‐Herold, Martin S. Maron, Gaurav Tiwari, Evan Appelbaum, Patrice Desvigne‐Nickens, Jeanette Schulz‐Menger, John Dimarco, Stefan Neubauer, Sarahfaye Dolman, Stefan K. Piechnik, Raymond Y. Kwong, Dong‐Yun Kim
article en
5 citations

Abstract

Proteomic profiling of sarcomeric HCM identified biomarkers associated with adverse imaging and clinical phenotypes. These circulating proteins are part of both established pathways, including neurohormonal activation and fibrosis, and less familiar pathways, including endothelial function and inflammatory proteins less well characterized in HCM. These findings highlight the value of plasma profiling to identify biomarkers of risk and to gain further insights into the pathophysiology of HCM.

Circulation Heart FailureVol. 17(12)
Brigham and Women's Hospital (US), Lahey Hospital and Medical Center (US), Beth Israel Deaconess Medical Center (US), Cleveland Clinic (US), University of Virginia Health System (US), John Radcliffe Hospital (GB), Lahey Medical Center (US), National Heart, Lung, and Blood Institute (US), MedStar Heart & Vascular Institute (US), Helios Hospital Berlin-Buch (DE), McGill University (CA)
Cytokinetics, National Institute for Health and Care Research, British Heart Foundation, National Institutes of Health, National Heart, Lung, and Blood Institute
Good health and well-being
Openalex Percentile: Top 12%
Cardiomyopathy and Myosin Studies
2.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.